Aurobindo Pharma’s subsidiary Eugia secures FDA nod for pazopanib tablets

Pallavi Madhiraju- December 6, 2024 0

Aurobindo Pharma Limited, through its wholly owned subsidiary Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) to ... Read More

Wanbury Limited reports 11.6% growth in revenue for Q2 FY25, EBITDA surges 19.6%

Pallavi Madhiraju- November 16, 2024 0

Wanbury Limited, a leading pharmaceutical company with a global footprint in active pharmaceutical ingredients (APIs) and domestic branded formulations, has announced a stellar financial performance ... Read More

Alembic Pharmaceuticals secures final approval from FDA for hypertension drug

Pallavi Madhiraju- October 20, 2024 0

Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP, in strengths ... Read More

Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence

Pallavi Madhiraju- October 17, 2024 0

Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More

Indoco Remedies secures final USFDA approval for generic Cetirizine Hydrochloride tablets

Pallavi Madhiraju- October 5, 2024 0

Indoco Remedies Limited has secured a significant regulatory win by receiving final approval from the United States Food and Drug Administration (USFDA) for its generic ... Read More

Alembic Pharmaceuticals wins big with FDA approval for new allergy eye drops

Pallavi Madhiraju- October 3, 2024 0

In a major development that could impact the over-the-counter pharmaceutical market, Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration ... Read More

Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment

Pallavi Madhiraju- October 2, 2024 0

Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its Enzalutamide Tablets, available in 40 mg and ... Read More

Dr. Reddy’s joins forces with Gilead Sciences to launch HIV drug Lenacapavir in India and 120 countries

Pallavi Madhiraju- October 2, 2024 0

In a historic development for HIV treatment worldwide, Dr. Reddy's Laboratories has announced a new partnership with Gilead Sciences to manufacture and commercialize a revolutionary ... Read More

Biocon faces regulatory heat as USFDA flags critical issues at its Bengaluru facility

Pallavi Madhiraju- September 30, 2024 0

In a significant development that has sent shockwaves through the biotechnology industry, Biocon Ltd. has come under fire from the U.S. Food and Drug Administration ... Read More

Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide

Pallavi Madhiraju- September 29, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More